Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 05, 2024 08:00 ET | Source: Mission Produce, Inc.

Mission Produce™ Provides Business Update for the Fiscal 2024 Fourth Quarter

OXNARD, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Mission Produce, Inc. (Nasdaq: AVO) (“Mission” or the “Company”), a world leader in sourcing, producing, and distributing fresh Hass avocados with...
November 04, 2024 21:00 ET | Source: MarketsandMarkets Research Pvt. Ltd.

Nutraceutical Products Market: Exploring Trends and Innovations Driving Growth | A $404.8 Billion Market by 2025

Delray Beach, FL, Nov. 04, 2024 (GLOBE NEWSWIRE) -- The global nutraceutical products market size has been experiencing significant growth, with a valuation of USD 267.4 billion in 2019 and an...
November 04, 2024 09:00 ET | Source: APB "Apranga"

„Aprangos” grupės apyvarta 2024 m. spalio mėnesį

„Aprangos“ grupės tinklo mažmeninė prekių apyvarta (su PVM) 2024 m. spalio mėnesį sudarė 33,1 mln. eurų ir buvo 3,3% didesnė nei 2023 m. spalio mėnesio apyvarta. 2024 m. sausio-spalio mėnesiais...
November 04, 2024 09:00 ET | Source: Apranga

Turnover of Apranga Group in October 2024

The retail turnover (including VAT) of the Apranga Group amounted to EUR 33.1 million in October 2024 and increased by 3.3% compared to October 2023. The retail turnover (including VAT) of Apranga...
November 04, 2024 06:00 ET | Source: Ilkka Oyj

Ilkka-konsernin osavuosikatsaus 1.1.-30.9.2024: Q3 oikaistu oman toiminnan liikevoitto ja osakekohtainen tulos paranivat, liikevaihto laski vaisussa markkinatilanteessa

Ilkka Oyj Osavuosikatsaus 4.11.2024, klo 13.00ILKKA-KONSERNIN OSAVUOSIKATSAUS 1.1.-30.9.2024: Q3 oikaistu oman toiminnan liikevoitto ja osakekohtainen tulos paranivat, liikevaihto laski...
October 31, 2024 16:00 ET | Source: Molecular Partners

Molecular Partners Q3 2024 Interim Management Statement: Multiple Updates Across Portfolio, Radio-DARPin candidate MP0712 preparing for clinical entry, MP0533 Phase 1 on-going

Radio-DARPin Therapy (RDT) Candidate MP0712 supported by in vivo data presented at the European Association of Nuclear Medicine (EANM) Congress; first-in-human start and initial clinical data expected...
October 31, 2024 09:00 ET | Source: e-therapeutics plc

e-therapeutics Announces Business Updates and Interim Results

LONDON, Oct. 31, 2024 (GLOBE NEWSWIRE) -- e-therapeutics plc, a company integrating computational power and biological data to discover life-transforming RNAi medicines, today announced business...
October 31, 2024 08:45 ET | Source: Illinois Lottery

Illinois Lottery Reports Record Results for Third Consecutive Year

CHICAGO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- As it celebrates its 50th anniversary, the Illinois Lottery is also celebrating another record-breaking year of sales and returns to the State of Illinois....
October 31, 2024 06:00 ET | Source: AB "Utenos trikotažas"

Skelbiami AB „Utenos trikotažas“ 2024 metų trečio ketvirčio rezultatai

Nors 2024 metų AB „Utenos trikotažas“ trečio ketvirčio pardavimai išlieka žemi, tačiau nuo ketvirčio pabaigos pastebimas nuosaikus užsakymų ir gamybos apimčių didėjimas. Šiuo metu AB „Utenos...
October 31, 2024 06:00 ET | Source: Utenos Trikotazas

AB Utenos trikotažas announces results for the third quarter of 2024

Although sales in the third quarter of 2024 remain low, there has been a moderate increase in orders and production volumes since the end of the quarter. Currently, AB Utenos trikotažas is operating...